{"id":"W2801498218","doi":"10.1038/s41571-018-0030-2","title":"Low-value approvals and high prices might incentivize ineffective drug development","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Medicine; Drug development; Drug; Portfolio; Drug approval; Incentive; Pipeline (software); Clinical trial; Value (mathematics); Actuarial science; Risk analysis (engineering); Intensive care medicine; Public economics; Pharmacology; Finance; Business; Internal medicine; Economics; Microeconomics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.01217801,0.001125142,0.009726153,0.0002347809,0.0002568031,0.00003412062,0.0009844571,0.008366371,0.0004724829],"category_scores_gemma":[0.005546556,0.000654985,0.00150817,0.0006113517,0.001571694,0.0000782703,0.0009023108,0.006342596,0.001126902],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003029978,"about_ca_system_score_gemma":0.001038973,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005602184,"about_ca_topic_score_gemma":0.00002736615,"domain_scores_codex":[0.9832672,0.009816927,0.004048963,0.001900024,0.0001110187,0.0008557914],"domain_scores_gemma":[0.9872442,0.00882565,0.002671603,0.000839744,0.0002212908,0.0001974709],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005937316,0.0005939567,0.00001206564,0.008892972,0.001095017,0.00001713533,0.00002293148,7.78097e-10,0.000001825211,0.0007596085,0.03061689,0.9579282],"study_design_scores_gemma":[0.0008727359,0.0006259212,0.00007837261,0.01125212,0.002509743,0.0001007532,0.000003393247,1.436613e-7,0.00003565618,0.0001712434,0.9836139,0.0007360255],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001748353,0.9895501,0.00008904772,0.0003655692,0.005085318,0.003261625,0.00004961599,0.00007020661,0.001511087],"genre_scores_gemma":[0.000004007436,0.9782373,0.0159304,0.001946175,0.0008239819,0.0003311719,0.0001926459,0.00006573381,0.002468603],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9571922,"threshold_uncertainty_score":0.9996508,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0935634486123407,"score_gpt":0.4775639335498192,"score_spread":0.3840004849374785,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}